Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03MFV
|
|||
| Former ID |
DIB000493
|
|||
| Drug Name |
MNLP-18
|
|||
| Synonyms |
MNLP-41; Glycosidase inhibitors (HCV Infection/Influenza); Imino sugar (antiviral), MNLpharma; Glycosidase inhibitors (HCV Infection/Influenza), MNLPharma
Click to Show/Hide
|
|||
| Indication | Virus infection [ICD-11: 1A24-1D9Z] | Preclinical | [1] | |
| Company |
MNLpharma Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycoside hydrolase (GlyH) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026397) | |||
| REF 2 | viral infection therapy, MNLpharma MNLpharma partnering opportunity, Worldwide, R & D Focus Drug News, May 29, 2006 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.